- Home
- FSTR vs ZURA Comparison
FSTR vs ZURA Comparison
Compare FSTR & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- ZURA
- Stock Information
- Founded
- FSTR 1902
- ZURA 2022
- Country
- FSTR United States
- ZURA United States
- Employees
- FSTR N/A
- ZURA N/A
- Industry
- FSTR Metal Fabrications
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSTR Industrials
- ZURA Health Care
- Exchange
- FSTR Nasdaq
- ZURA Nasdaq
- Market Cap
- FSTR 256.5M
- ZURA 69.9M
- IPO Year
- FSTR N/A
- ZURA N/A
- Fundamental
- Price
- FSTR $24.42
- ZURA $1.31
- Analyst Decision
- FSTR Hold
- ZURA Buy
- Analyst Count
- FSTR 1
- ZURA 7
- Target Price
- FSTR $25.00
- ZURA $14.33
- AVG Volume (30 Days)
- FSTR 34.6K
- ZURA 708.2K
- Earning Date
- FSTR 08-05-2025
- ZURA 08-08-2025
- Dividend Yield
- FSTR N/A
- ZURA N/A
- EPS Growth
- FSTR 361.43
- ZURA N/A
- EPS
- FSTR 3.34
- ZURA N/A
- Revenue
- FSTR $504,237,000.00
- ZURA N/A
- Revenue This Year
- FSTR $3.72
- ZURA N/A
- Revenue Next Year
- FSTR $5.50
- ZURA N/A
- P/E Ratio
- FSTR $7.41
- ZURA N/A
- Revenue Growth
- FSTR N/A
- ZURA N/A
- 52 Week Low
- FSTR $14.23
- ZURA $0.97
- 52 Week High
- FSTR $29.78
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- FSTR 77.10
- ZURA 59.63
- Support Level
- FSTR $23.41
- ZURA $1.00
- Resistance Level
- FSTR $24.61
- ZURA $1.45
- Average True Range (ATR)
- FSTR 0.70
- ZURA 0.10
- MACD
- FSTR 0.35
- ZURA 0.03
- Stochastic Oscillator
- FSTR 99.62
- ZURA 68.89
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.